[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100370529":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":24,"centralContacts":29,"locations":36,"responsibleParty":97,"collaborators":19,"id":99,"slug":100,"hasResults":101,"nctId":102,"briefTitle":103,"officialTitle":104,"acronym":105,"eligibilityCriteria":106,"healthyVolunteers":101,"sex":107,"minAge":108,"maxAge":19,"enrollmentInfo":109,"targetDuration":19,"studyType":112,"phases":113,"briefSummary":115,"conditions":116,"keywords":120,"overallStatus":39,"whyStopped":19,"lastUpdateSubmitDate":125,"lastUpdatePostDateStruct":126,"startDateStruct":129,"completionDateStruct":131,"leadSponsor":133,"locationsCount":134},{"fullName":5,"class":6},"Institut du Cancer de Montpellier - Val d'Aurelle","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Biological collection","EXPERIMENTAL","Biological collection\n\nFor all the patients include in the study :\n\nsamples of blood samples collected before and during treatment. In parallel to this biological collection, standardized clinical data will be entered into a database\n\nAncillary study :\n\nFor metastatic thyroïd cancer and neuroendocrine tumor : anapath blocks of the initial diagnosis will be archived and dosimetric data will be collected for the cycle 1 For neuroendocrine tumor : blood sample additionnal will be realized at the cycle 1 (pre and post treatment)",[13,14],"Other: Biological collection","Other: tumor collection",[16,20],{"type":6,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"The biological collection will also include samples of blood samples collected before and during treatment.",[9],null,{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":19},"tumor collection","Tumor collection (diagnosis) will be done for thyroid cancer and neuroencrine",[9],[25],{"name":26,"affiliation":27,"role":28},"Emmanuel DESHAYES, MD","Institut régional du Cancer Montpellier","STUDY_CHAIR",[30],{"name":31,"role":32,"phone":33,"phoneExt":34,"email":35},"Aurore MOUSSION","CONTACT","0467613102","+33","DRCI-icm105@icm.unicancer.fr",[37,54,68,84],{"facility":38,"status":39,"city":40,"state":41,"zip":19,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Hopital Haut Lévêque","RECRUITING","Bordeaux","Aquitaine","France","FR",{"type":45,"coordinates":46},"Point",[47,48],-0.58046,44.84124,{"lat":48,"lon":47},[51],{"name":52,"role":32,"phone":19,"phoneExt":19,"email":53},"Elif HINDIE, MD","elif.hindie@chu-bordeaux.fr",{"facility":55,"status":56,"city":57,"state":58,"zip":19,"country":42,"countryCode":43,"cosmosGeoPoint":59,"geoPoint":63,"contacts":64},"Hôpital LaTimone","NOT_YET_RECRUITING","Marseille","Bouches Du Rhône",{"type":45,"coordinates":60},[61,62],5.38107,43.29695,{"lat":62,"lon":61},[65],{"name":66,"role":32,"phone":19,"phoneExt":19,"email":67},"David TAIEB, MD","David.TAIEB@ap-hm.fr",{"facility":69,"status":39,"city":70,"state":19,"zip":71,"country":42,"countryCode":43,"cosmosGeoPoint":72,"geoPoint":76,"contacts":77},"Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle","Montpellier","34298",{"type":45,"coordinates":73},[74,75],3.87635,43.61093,{"lat":75,"lon":74},[78,82],{"name":79,"role":32,"phone":80,"phoneExt":19,"email":81},"Marc Ychou, MD, PhD","33-4-6761-3066","marc.ychou@icm.unicancer.fr",{"name":31,"role":32,"phone":33,"phoneExt":19,"email":83},"aurore.moussion@icm.unicancer.fr",{"facility":85,"status":39,"city":86,"state":19,"zip":87,"country":42,"countryCode":43,"cosmosGeoPoint":88,"geoPoint":92,"contacts":93},"Institut Universitaire du Cancer de Toulouse","Toulouse","31100",{"type":45,"coordinates":89},[90,91],1.44367,43.60426,{"lat":91,"lon":90},[94],{"name":95,"role":32,"phone":19,"phoneExt":19,"email":96},"Lawrence DIERICKX, MD","Dierickx.Lawrence@iuct-oncopole.fr",{"type":98,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR","100370529","clinico-biological-database-in-patients-treated-with-metabolic-radiotherapy-in-the-nuclear-medicine-department-100370529",false,"NCT04104529","Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department","Establishment of a Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department","BCB RIV","Inclusion Criteria:\n\n* Age ≥ at 18 years old,\n* Patient treated in the Nuclear Medicine Department for the treatment by metabolic radiotherapy,\n* Patient treated as part of his treatment for:\n\n  * thyroid cancer,\n  * a neuroendocrine tumor or\n  * prostate cancer.\n* Patient having accepted the complementary blood sample,\n* Patient having given his informed, written and express consent.\n\nExclusion Criteria:\n\n* Patient not affiliated to a social security scheme,\n* Subject under tutelage, curatorship or safeguard of justice,\n* Patient in an emergency situation\n* Patient whose regular monitoring is a priori impossible for psychological, family, social or geographical reasons,\n* Pregnant and \u002F or breastfeeding woman","ALL","18 Years",{"count":110,"type":111},350,"ESTIMATED","INTERVENTIONAL",[114],"NA","Development of a clinico-biological database allowing the provision of clinical data and corresponding biological materials to the medical and scientific community.",[117,118,119],"Thyroid Cancer","Prostate Cancer","Neuroendocrine Tumors",[121,122,123,124],"thyroid cancer","prostate cancer","neuroendocrine tumors","nuclear medecine","2026-06-02",{"date":127,"type":128},"2026-06-04","ACTUAL",{"date":130,"type":128},"2019-10-28",{"date":132,"type":111},"2026-10",{"name":5,"class":6},4]